ICL's Q2 Beat Wasn't Just Big Numbers: Potash and Bromine Prices Just Made the Re-rating Case

Q2 results strengthened the case for a better full-year setup

The standout feature of ICL's quarter was not just the size of the numbers, but how widely they improved. sales rose 17% to $2.1 billion, adjusted EBITDA climbed 28% to $448 million, adjusted net income rose 35% to $149 million, and free cash flow increased 34% to $94 million. After Q1 sales of $2.0 billion and adjusted EBITDA of $412 million, this looked less like a one-off spike and more like momentum building across two quarters. Management's continued EBITDA outlook of $1.5 billion to $1.7 billion for the full year reinforced that read.

The positive case: pricing and volume both improved

Investors can fairly read this quarter as a pricing story that also showed up in cash. Higher prices for potash, bromine, and phosphates drove sales growth, while bromine helped Industrial Products post its best quarterly performance since late 2022. In potash, investors got both a better price and more volume: Average Potash Price -- $376 CIF per ton, increasing 13% year over year and 4% on a sequential basis, while Potash Production Volume -- 1,058,000 metric tons, growing 11%.

The caution case: cost inflation still mattered

The counterargument is also easy to see. Management said price improvements and volume gains offset $100 million in higher raw material costs, and phosphate profits improved only modestly despite higher prices. In other words, not every dollar of stronger demand automatically became profit.

Why the bullish read still has weight

The cash picture is the reason the bullish case still matters. Free cash flow of $94 million covered the $75 million dividend, which was 50% of adjusted net income. That does not prove durability, but it does show the business was converting part of this pricing strength into shareholder cash rather than merely recording higher revenue.

Industrial Products and Potash showed where pricing power worked best

The key split in this quarter was not whether sales were strong. It was which businesses turned stronger sales into stronger profit. By that measure, the clearest winners were bromine in Industrial Products and potash in the Potash division.

Industrial Products had the sharpest profit leverage

Industrial Products was the cleanest example. Sales rose 30% to $414 million, while EBITDA jumped to Industrial Products EBITDA -- $130 million, growing 88%. Management said the segment benefited from higher bromine prices and improved demand in the electronics market, pushing the division to its best quarterly performance since late 2022.

Potash combined better pricing with higher volume

Potash followed a similar, if broader, lever. Potash Sales -- $468 million, rising 22%, while Potash EBITDA -- $154 million, increasing 34%. The driver was straightforward: Average Potash Price -- $376 CIF per ton, increasing 13% year over year and 4% on a sequential basis, and Potash Production Volume -- 1,058,000 metric tons, growing 11%. Management also said potash EBITDA benefited because the company focused on higher-margin global markets, so investors got a mix of price, volume, and portfolio discipline.

Phosphate Solutions and Growing Solutions showed the limits of the tailwind

The same sales strength did not produce the same profit result everywhere. In Phosphate Solutions, Phosphate Solutions Division Sales: $722 million, up 13%, but Phosphate Solutions Division EBITDA: $136 million, up slightly year over year. Management said higher phosphate prices helped, but a sharp rise in sulfur costs partially offset that benefit.

Growing Solutions showed the same pressure from another angle. Growing Solutions Division Sales: $605 million, increasing 12%, but Growing Solutions Division EBITDA: $50 million, declining from the prior year. Revenue kept moving forward, but input-cost pressure still limited profitability.

The next test is whether this quarter is durable

This quarter looks meaningfully better than average, but it is still too early to call it a fully proven regime change. The real test is whether potash pricing stays firm and whether ICL can prevent cost inflation from absorbing the upside in phosphates and crop nutrition.

That is also why strategic execution still matters. If management can keep building higher-margin specialty businesses, investors may start to value ICL less as a pure commodity cycle and more as a company with a broader growth path. For now, though, the main evidence is simple: pricing worked where it could, profits followed where pricing power was strongest, and cash improved alongside earnings.